IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 104 filers reported holding IVERIC BIO INC in Q3 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,986 | +73.0% | 203,000 | +7.0% | 0.01% | +100.0% |
| Q1 2023 | $4,615 | +1485.9% | 189,700 | +1294.9% | 0.01% | – |
| Q4 2022 | $291 | -100.0% | 13,600 | -94.5% | 0.00% | -100.0% |
| Q3 2021 | $4,032,000 | +213.3% | 248,300 | +8.8% | 0.01% | +400.0% |
| Q3 2020 | $1,287,000 | -77.5% | 228,180 | -79.7% | 0.00% | -80.0% |
| Q2 2020 | $5,719,000 | +34.2% | 1,121,380 | -9.5% | 0.01% | +25.0% |
| Q1 2020 | $4,262,000 | -53.1% | 1,238,980 | +16.9% | 0.00% | -42.9% |
| Q4 2019 | $9,097,000 | +577.9% | 1,060,280 | -11.5% | 0.01% | +600.0% |
| Q3 2019 | $1,342,000 | -16.3% | 1,198,255 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $1,604,000 | – | 1,233,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |